(Reuters) - Consumer watchdog Public Citizen said it petitioned U.S. health regulators to withdraw approval of Sanofi SA's Seprafilm and order a recall, saying the surgical implant has been associated with side effects including death.
Seprafilm, developed by Genzyme, is used to reduce abnormal internal scarring following surgery, by separating tissues and organs while they heal. The anti-adhesion barrier device was approved by the U.S. Food and Drug Administration in 1996.
Help employers find you! Check out all the jobs and post your resume.
Seprafilm, developed by Genzyme, is used to reduce abnormal internal scarring following surgery, by separating tissues and organs while they heal. The anti-adhesion barrier device was approved by the U.S. Food and Drug Administration in 1996.
Help employers find you! Check out all the jobs and post your resume.
